Search results
Our iconic brands have a new home where thoughtful everyday care meets scientific precision. As a global consumer health leader, Kenvue touches the lives of more than a billion people across the globe.
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue is the proprietor of well-known brands such as Aveeno, Band-Aid, Benadryl, Combantrin, Zyrtec, Johnson's, Listerine, Mylanta, Neutrogena, Trosyd, Tylenol, and Visine.
Sep 28, 2022 · Kenvue Post-Separation: A Leading Global Consumer Health Company with Iconic Brands and Commitment to Continued Innovation. Kenvue will become a standalone leading global consumer health company in 2023, subject to legal requirements including consultation with works councils and employee representatives, as required.
Jul 31, 2023 · If you’ve heard of Kenvue, you may already know that we’re a global consumer health company. But beyond our portfolio of iconic brands, Kenvue is built on a foundation of core values, which fuel our 22,000+ global team members every day. Here’s what you need to know: 1. You already know us
Through our iconic Kenvue brands, we connect with ~1.2 billion people globally in their daily rituals and the moments that matter most.
May 4, 2023 · Johnson & Johnson's consumer-health spinoff Kenvue started trading on the New York Stock Exchange under the stock ticker KVUE. Thursday's move values the new company at roughly $50 billion....
May 3, 2023 · J&J's consumer health spinoff, Kenvue, is expected to set an initial public offering price Wednesday night and trade Thursday on the New York Stock Exchange.
Sep 28, 2022 · Kenvue Post-Separation: A Leading Global Consumer Health Company with Iconic Brands and Commitment to Continued Innovation
Kenvue is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage and propelled forward by science, our iconic brands — including Aveeno ...
May 7, 2024 · Kenvue will cut 4% of its global workforce amid investments to grow its key brands, the Tylenol and Band-Aid maker said on Tuesday, as it topped beat Wall Street estimates for first-quarter...
